Principal investigators (PIs) are required to submit an application to use rDNA, synthetic nucleic acids, biohazardous agents or unfixed human fluids and tissues prior to the initiation of the ...
21hon MSN
Adjustable DNA 'shield' can control timing and rate at which mRNA produces proteins in vivo
RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback